We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Enpro
NPO
$6.09B
| $2.74M | 0.01% |
20,546
-1,529
| -7% | -$162K |
|
852
Chegg
CHGG
$81.8M
| $2.73M | 0.01% |
307,962
-342,589
| -53% | -$4.15M |
|
853
Stagwell
STGW
$2.05B
| $2.73M | 0.01% |
379,152
-25,185
| -6% | -$166K |
|
|
AVNS
854
DELISTED
Avanos Medical
AVNS
| $2.73M | 0.01% |
106,774
+14,341
| +16% | +$378K |
|
855
COPT Defense Properties
CDP
$3.9B
| $2.73M | 0.01% |
114,905
+2,104
| +2% | +$49.1K |
|
|
DADA
856
DELISTED
Dada Nexus
DADA
| $2.71M | 0.01% |
510,939
+220,059
| +76% | +$1.33M |
|
857
Enovis
ENOV
$1.07B
| $2.7M | 0.01% |
42,158
+3,473
| +9% | +$198K |
|
858
Mitek Systems
MITK
$797M
| $2.67M | 0.01% |
246,487
-92,836
| -27% | -$907K |
|
859
Illinois Tool Works
ITW
$76.5B
| $2.65M | 0.01% |
10,585
-1,616
| -13% | -$378K |
|
|
ORTX
860
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.65M | 0.01% |
508,222
-1,417,155
| -74% | -$7.22M |
|
861
ONE Gas
OGS
$4.8B
| $2.64M | 0.01% |
34,393
+4,025
| +13% | +$322K |
|
862
Maravai LifeSciences
MRVI
$1.03B
| $2.64M | 0.01% |
212,476
-13,148
| -6% | -$177K |
|
863
Hain Celestial
HAIN
$55.1M
| $2.64M | 0.01% |
210,939
-432,179
| -67% | -$6.36M |
|
864
Medpace
MEDP
$17.3B
| $2.64M | 0.01% |
10,987
-407
| -4% | -$84.5K |
|
865
Rackspace Technology
RXT
$892M
| $2.62M | 0.01% |
964,743
+100,354
| +12% | +$166K |
|
|
CIO
866
DELISTED
City Office REIT
CIO
| $2.6M | 0.01% |
467,046
+41,476
| +10% | +$226K |
|
867
BancFirst
BANF
$3.69B
| $2.58M | 0.01% |
28,092
+167
| +0.6% | +$14K |
|
868
Trimble
TRMB
$13.6B
| $2.58M | 0.01% |
48,763
+15,494
| +47% | +$758K |
|
|
869
Darden Restaurants
DRI
$23.9B
| $2.58M | 0.01% |
15,435
-795,104
| -98% | -$125M |
|
|
BECN
870
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $2.57M | 0.01% |
30,934
-801
| -3% | -$52.9K |
|
871
Federal Signal
FSS
$7.06B
| $2.57M | 0.01% |
40,066
-30,073
| -43% | -$1.66M |
|
872
Groupon
GRPN
$797M
| $2.55M | 0.01% |
431,920
-5,353
| -1% | -$23.7K |
|
873
GEN Restaurant Group
GENK
$8.58M
| $2.55M | 0.01% |
+150,000
| New | +$2.36M |
|
874
KLA
KLAC
$221B
| $2.54M | 0.01% |
52,450
+26,580
| +103% | +$1.11M |
|
|
DOCU
875
DocuSign
DOCU
$13.3B
| $2.53M | 0.01% |
49,610
+27,719
| +127% | +$1.47M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.